购物车
- 全部删除
- 您的购物车当前为空
Sirpiglenastat (DRP-104) 是一种谷氨酰胺 (glutamine) 拮抗剂,是DON的前药,具有抗肿瘤活性,通过抑制谷氨酰胺代谢和刺激先天性和适应性免疫系统来发挥作用。
为众多的药物研发团队赋能,
让新药发现更简单!
Sirpiglenastat (DRP-104) 是一种谷氨酰胺 (glutamine) 拮抗剂,是DON的前药,具有抗肿瘤活性,通过抑制谷氨酰胺代谢和刺激先天性和适应性免疫系统来发挥作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,490 | 现货 | |
5 mg | ¥ 3,730 | 现货 | |
10 mg | ¥ 5,470 | 现货 | |
25 mg | ¥ 8,190 | 现货 | |
50 mg | ¥ 10,800 | 现货 |
产品描述 | Sirpiglenastat (DRP-104) is a glutamine antagonist, a prodrug of DON, with antitumor activity that acts by inhibiting glutamine metabolism and stimulating the innate and adaptive immune system. |
体外活性 | Treatment with Sirpiglenastat (DRP-104) exhibits broad immune cell modulation effects, including an increase in T cells, NK cells, and macrophages. Sirpiglenastat also reduces the levels of pro-tumorigenic cytokines such as VEGF and KC (IL-8)[1]. |
体内活性 | In CT26 bearing mice, treatment with Sirpiglenastat (DRP-104) at a dose of 0.5 mg/kg through subcutaneous injection once a day for 5 days results in a 90% inhibition of tumor growth by day 12, with a median survival of 36 days[1].Additionally, Sirpiglenastat treatment (0.5 mg/kg; s.c) significantly inhibits tumor growth in the H22 model[1]. |
别名 | DRP-104 |
分子量 | 441.48 |
分子式 | C22H27N5O5 |
CAS No. | 2079939-05-0 |
Smiles | C([C@@H](C(N[C@H](C(OC(C)C)=O)CCC(C=[N+]=[N-])=O)=O)NC(C)=O)C=1C=2C(NC1)=CC=CC2 |
存储 | keep away from direct sunlight,keep away from moisture,store at low temperature | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (181.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容